Global Solid Tumor Therapeutics Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Solid Tumor Therapeutics Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Type (Genetic Testing, and Conventional Testing), Application (Prostate, Breast, Colorectal, Endometrial, Lung, Melanoma, Brain, Thyroid, Liver, Ovarian, and Others), End Users (Hospitals, Pharmaceutical and biotechnology companies, Contract research organizations, and Academic research institutions), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Solid Tumor Therapeutics Market was valued at USD 26,763.3 million in 2023 and is expected to reach USD 47,377.7 million by 2031 while growing at a CAGR of 7.4% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global solid tumor therapeutics market growth. The Solid Tumor Therapeutics Program (STTP) aims to identify somatic and germline genomic alterations present in different types of solid tumors, both common and unique. It seeks to leverage these findings to develop innovative therapies that enhance the well-being and survival of cancer patients.
Continual progress in comprehending tumor biology and crafting targeted therapies, coupled with the rising incidence of solid tumors and government backing, propels market expansion. Nonetheless, obstacles such as the high cost of treatment and regulatory hurdles impede further growth.
Furthermore, the global solid tumor therapeutics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Type Analysis
The Global Solid Tumor Therapeutics Market is segmented among Genetic Testing, and Conventional Testing, based on Type. In 2023, Genetic Testing accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global Solid Tumor Therapeutics Market is segmented among Prostate, Breast, Colorectal, Endometrial, Lung, Melanoma, Brain, Thyroid, Liver, Ovarian, and Others, based on Application. In 2023, Prostate accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Solid Tumor Therapeutics Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are QIAGEN, QUEST DIAGNOSTICS INCORPORATED, Abbott Laboratories, Agilent Technologies Inc., Biocare Medical LLC, F. Hoffmann-La Roche AG, ILLUMINA, INC., MedGenome Labs Private Ltd, MYRIAD GENETICS, INC., Thermo Fisher Scientific, Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Solid Tumor Therapeutics Market Dynamics
Drivers
Restraints
Opportunity
4. Global Solid Tumor Therapeutics Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Solid Tumor Therapeutics Market Segmentation, By Type
Global Solid Tumor Therapeutics Market Share Analysis, By Type
Global Solid Tumor Therapeutics Market Growth Analysis, By Type
Global Solid Tumor Therapeutics Market Trends, By Type
o Genetic Testing
o Conventional Testing
6. Global Solid Tumor Therapeutics Market Segmentation, By Application
Global Solid Tumor Therapeutics Market Share Analysis, By Application
Global Solid Tumor Therapeutics Market Growth Analysis, By Application
Global Solid Tumor Therapeutics Market Trends, By Application
o Prostate
o Breast
o Colorectal
o Endometrial
o Lung
o Melanoma
o Brain
o Thyroid
o Liver
o Ovarian
o Others
7. Global Solid Tumor Therapeutics Market Segmentation, By End User
Global Solid Tumor Therapeutics Market Share Analysis, By End User
Global Solid Tumor Therapeutics Market Growth Analysis, By End User
Global Solid Tumor Therapeutics Market Trends, By End User
o Hospitals
o Pharmaceutical and biotechnology companies
o Contract research organizations
o Academic research institutions
8. Global Solid Tumor Therapeutics Market Segmentation, By Region
Global Solid Tumor Therapeutics Market Share Analysis, By Region
Global Solid Tumor Therapeutics Market Growth Analysis, By Region
Global Solid Tumor Therapeutics Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
QIAGEN*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
QUEST DIAGNOSTICS INCORPORATED
Abbott Laboratories
Agilent Technologies Inc.
Biocare Medical LLC
F. Hoffmann-La Roche AG
ILLUMINA, INC.
MedGenome Labs Private Ltd
MYRIAD GENETICS, INC.
Thermo Fisher Scientific, Inc.
*Similar analysis will be provided for each company listed above.
